Pemzek 16 mg, Tabletten - 30 Swissmedic Key 62498010 Registration Holder AstraZeneca AG Name Pemzek 16 mg, Tabletten Date of registration 06.01.2012 Introduction of Sequence 06.01.2012 ATC-Classification Candesartan (C09CA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.10. Show package size 30 Index Therapeuticus (Swissmedic) 02.07.10. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680624980105 Medication Code Synthetika Pharmacode Disponibility
Composition candesartanum cilexetilum 16 mg, carmellosum calcicum, hydroxypropylcellulosum, lactosum monohydricum 81.4 mg, magnesii stearas, maydis amylum, macrogolum 8000, E 172 (rubrum), pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 16 mg
BAG: Active Agent Dose Candesartanum Cilexetil 16 mg
Inactive agents Dose additional_information (Rubrum) Carmellosum Calcicum E 172 color. Hydroxypropylcellulosum Lactose Monohydrate 81.4 mg Macrogol 8000 Magnesii Stearas Maydis Amylum Pro Compresso
Source Data was imported : 02.09.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
